Stephen W. Mason

4.7k citations

31 papers · 1.7k indexed · h-index 21

Co-authors: Jack Greenblatt Justin R. Nodwell Steve Titolo Nathalie Goudreau Christopher T. Lemke Anne‐Marie Faucher Joyce Li Brenda Andrews
Topics: HIV Research and Treatment (14 papers)HIV/AIDS drug development and treatment (11 papers)RNA and protein synthesis mechanisms (6 papers)
Cited by: Virology Infectious Diseases Genetics
Journals: Nature Proceedings of the National Academy of Sciences Nucleic Acids Research
Partner nations: Canada United States Germany

In The Last Decade

Stephen W. Mason

31 papers receiving 1.7k citations

Peers

Countries citing papers authored by Stephen W. Mason

Since Specialization

Citations

This map shows the geographic impact of Stephen W. Mason's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen W. Mason with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen W. Mason more than expected).

Fields of papers citing papers by Stephen W. Mason

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen W. Mason. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen W. Mason. The network helps show where Stephen W. Mason may publish in the future.

Co-authorship network of co-authors of Stephen W. Mason

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen W. Mason. A scholar is included among the top collaborators of Stephen W. Mason based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen W. Mason. Stephen W. Mason is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Blockade of the PD-1 axis alone is not sufficient to activate HIV-1 virion production from CD4+ T cells of individuals on suppressive ART 2019 ·PLoS ONE ·John Bui,Joshua C. Cyktor,Elizabeth Fyne,(unknown),Stephen W. Mason,John W. Mellors	20
2	Virus-like Vesicles Expressing Multiple Antigens for Immunotherapy of Chronic Hepatitis B 2019 ·iScience ·Timur O. Yarovinsky,Stephen W. Mason,(unknown),(unknown),Maria Haslip,Bhaskara Reddy Madina,Xianyong Ma,(unknown),Carolina Chiale,(unknown),Bijan Almassian,John K. Rose,Michael D. Robek,Valerian Nakaar	11
3	Comparison of antiviral resistance across acute and chronic viral infections 2018 ·Antiviral Research ·Stephen W. Mason,John P. DeVincenzo,Stephen Toovey,Jim Zhen Wu,Richard J. Whitley	54
4	Safety and efficacy of anti-PD-L1 therapy in the woodchuck model of HBV infection 2018 ·PLoS ONE ·Scott Balsitis,(unknown),(unknown),Susan Chaniewski,Steven M. LeVine,Michael Wichroski,(unknown),Yunling Song,(unknown),James Loy,Chris M. Thompson,Jacob Lesniak,(unknown),Narendra S. Kishnani,Stephan Menne,Mark I. Cockett,Renuka Iyer,Stephen W. Mason,Daniel J. Tenney	37
5	Clinical Trial of the Anti-PD-L1 Antibody BMS-936559 in HIV-1 Infected Participants on Suppressive Antiretroviral Therapy 2017 ·The Journal of Infectious Diseases ·Cynthia L. Gay,Ronald J. Bosch,Justin Ritz,Jason Hataye,Evgenia Aga,Randall L. Tressler,Stephen W. Mason,Carey Hwang,Dennis M. Grasela,Neelanjana Ray,(unknown),John M. Coffin,Edward P. Acosta,Richard A. Koup,John W. Mellors,Joseph J. Eron	180
6	A Small Molecule Inhibitor Selectively Induces Apoptosis in Cells Transformed by High Risk Human Papilloma Viruses 2016 ·PLoS ONE ·Amy K. Sheaffer,Min S. Lee,Huilin Qi,Susan Chaniewski,Xiaofan Zheng,Glen A. Farr,(unknown),David Harden,Ming Lei,Liang Schweizer,Jacques Friborg,(unknown),Fiona McPhee,Robert G. Gentles,Brett R. Beno,(unknown),Stephen W. Mason	3
7	Minimizing the Contribution of Enterohepatic Recirculation to Clearance in Rat for the NCINI Class of Inhibitors of HIV 2014 ·ACS Medicinal Chemistry Letters ·Lee D. Fader,Rebekah Carson,Sébastien Morin,François Bilodeau,Catherine Chabot,Ted Halmos,Murray D. Bailey,Stephen H. Kawai,René Coulombe,Steven R. LaPlante,(unknown),Araz Jakalian,Michel Garneau,Jianmin Duan,Stephen W. Mason,Bruno Simoneau,Craig Fenwick,Youla S. Tsantrizos,Christiane Yoakim	14
8	Monitoring Binding of HIV‐1 Capsid Assembly Inhibitors Using ¹⁹F Ligand‐and ¹⁵N Protein‐Based NMR and X‐ray Crystallography: Early Hit Validation of a Benzodiazepine Series 2013 ·ChemMedChem ·Nathalie Goudreau,René Coulombe,Anne‐Marie Faucher,Chantal Grand‐Maître,(unknown),Christopher T. Lemke,Éric Malenfant,Yves Bousquet,Lee D. Fader,Bruno Simoneau,Jean‐François Mercier,Steve Titolo,Stephen W. Mason	14
9	Optimization of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of HIV capsid assembly inhibitors 1: Addressing configurational instability through scaffold modification 2013 ·Bioorganic & Medicinal Chemistry Letters ·Lee D. Fader,Serge Landry,Sébastien Morin,Stephen H. Kawai,Yves Bousquet,Oliver Hucke,Nathalie Goudreau,Christopher T. Lemke,Pierre Bonneau,Steve Titolo,Stephen W. Mason,Bruno Simoneau	15
10	Discovery and Structural Characterization of a New Inhibitor Series of HIV-1 Nucleocapsid Function: NMR Solution Structure Determination of a Ternary Complex Involving a 2:1 Inhibitor/NC Stoichiometry 2013 ·Journal of Molecular Biology ·Nathalie Goudreau,Oliver Hucke,Anne‐Marie Faucher,Chantal Grand‐Maître,Olivier Lepage,Pierre Bonneau,Stephen W. Mason,Steve Titolo	39
11	A novel inhibitor-binding site on the HIV-1 capsid N-terminal domain leads to improved crystallizationviacompound-mediated dimerization 2013 ·Acta Crystallographica Section D Biological Crystallography ·Christopher T. Lemke,Steve Titolo,Nathalie Goudreau,Anne‐Marie Faucher,Stephen W. Mason,Pierre Bonneau	27
12	Inhibition of HIV-1 capsid assembly: Optimization of the antiviral potency by site selective modifications at N1, C2 and C16 of a 5-(5-furan-2-yl-pyrazol-1-yl)-1H-benzimidazole scaffold 2012 ·Bioorganic & Medicinal Chemistry Letters ·Martin Tremblay,Pierre Bonneau,Yves Bousquet,Patrick DeRoy,Jianmin Duan,Martin Duplessis,Alexandre Gagnon,Michel Garneau,Nathalie Goudreau,Ingrid Guse,Oliver Hucke,Stephen H. Kawai,Christopher T. Lemke,Stephen W. Mason,Bruno Simoneau,(unknown),Steve Titolo,Christiane Yoakim	28
13	Assay Optimization: A Statistical Design of Experiments Approach 2007 ·Clinics in Laboratory Medicine ·(unknown),Carol Homon,Mohammed A. Kashem,Stephen W. Mason,Richard M. Nelson,Lori Patnaude,Jeffrey D. Yingling,Paul B. Taylor	37
14	Assay Optimization: A Statistical Design of Experiments Approach 2006 ·JALA Journal of the Association for Laboratory Automation ·(unknown),Carol Homon,Mohammed A. Kashem,Stephen W. Mason,Richard M. Nelson,Lori Patnaude,Jeffrey D. Yingling,Paul B. Taylor	14
15	Polyadenylation-dependent screening assay for respiratory syncytial virus RNA transcriptase activity and identification of an inhibitor 2004 ·Nucleic Acids Research ·Stephen W. Mason	37
16	RNA polymerase I transcription termination: similar mechanisms are employed by yeast and mammals 1 1Edited by M. Yaniv 1997 ·Journal of Molecular Biology ·Stephen W. Mason,Michael Wallisch,Ingrid Grummt	26
17	Identification of a transcript release activity acting on ternary transcription complexes containing murine RNA polymerase I 1997 ·The EMBO Journal ·Stephen W. Mason	31
18	Transcriptional antitermination 1993 ·Nature ·Jack Greenblatt,Justin R. Nodwell,Stephen W. Mason	195
19	Direct interaction between two Escherichia coli transcription antitermination factors, NusB and ribosomal protein S10 1992 ·Journal of Molecular Biology ·Stephen W. Mason,Joyce Li,Jack Greenblatt	61
20	Assembly of transcription elongation complexes containing the N protein of phage lambda and the Escherichia coli elongation factors NusA, NusB, NusG, and S10. 1991 ·Genes & Development ·Stephen W. Mason,Jack Greenblatt	121

About Stephen W. Mason

Stephen W. Mason is a scholar working on Virology, Infectious Diseases and Hepatology, having authored 31 papers that have together received 1.7k indexed citations. Recurring topics across this work include HIV Research and Treatment (14 papers), HIV/AIDS drug development and treatment (11 papers) and RNA and protein synthesis mechanisms (6 papers). The work is most often cited by research in Virology (470 citations), Infectious Diseases (494 citations) and Genetics (392 citations). Stephen W. Mason has collaborated with scholars based in Canada, United States and Germany. Frequent co-authors include Jack Greenblatt, Justin R. Nodwell, Steve Titolo, Nathalie Goudreau, Christopher T. Lemke, Anne‐Marie Faucher, Joyce Li, Brenda Andrews, Yuen Ho and Merl F. Hoekstra. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact